BMI1 and esophageal squamous cell carcinoma: Immunohistochemical analysis of BMI1 and/or Gli-1 in all post-CRT ESCC patients seems highly informative and convenient in the stratification of patients into subgroups with a distinct likelihood of therapy failure.